Literature DB >> 35831621

[Adverse effects of opioids, antidepressants and anticonvulsants on sex hormones : Often unnoticed but clinically relevant].

Stefan Wirz1, Michael Schenk2, Kristin Kieselbach3.   

Abstract

Androgen insufficiency under treatment with opioids, antidepressants and anticonvulsants in chronic pain diseases is a side effect with a high prevalence. It can lead to clinical metabolic alterations, adynamia, stress intolerance, anemia or osteoporosis and has a significant impact on the quality of life. Opioids, antidepressants and anticonvulsants affect the hypothalamic-pituitary-gonadal axis of sex hormones. A urologist, andrologist or endocrinologist should be involved in the treatment at an early stage. The recommendation of a differential therapeutic selection of certain substances is only indicative and does not meet evidential criteria. The indications for androgen substitution must be individualized and in consideration of the risk-benefit profile. Awareness of this side effect of an otherwise lege artis medicinal pain therapy must be sharpened and compulsory included in the differential diagnostic considerations.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Androgen deficiency, opioid-induced; Cancer pain, chronic; Hypogonadism, opioid-induced; Non-cancer pain, chronic; Testosterone replacement therapy

Mesh:

Substances:

Year:  2022        PMID: 35831621     DOI: 10.1007/s00482-022-00655-9

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.629


  73 in total

1.  Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment.

Authors:  Annica Rhodin; Mats Stridsberg; Torsten Gordh
Journal:  Clin J Pain       Date:  2010-06       Impact factor: 3.442

Review 2.  MECHANISMS OF ENDOCRINOLOGY: Endocrinology of opioids

Authors:  Athanasios Fountas; Shu Teng Chai; Chrysoula Kourkouti; Niki Karavitaki
Journal:  Eur J Endocrinol       Date:  2018-10-01       Impact factor: 6.664

Review 3.  Opioid Related Endocrinopathy.

Authors:  Jeffrey A Gudin; Adam Laitman; Srinivas Nalamachu
Journal:  Pain Med       Date:  2015-10       Impact factor: 3.750

Review 4.  Opioid-induced androgen deficiency (OPIAD).

Authors:  Howard S Smith; Jennifer A Elliott
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

5.  DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production.

Authors:  Harry W Daniell
Journal:  J Pain       Date:  2006-12       Impact factor: 5.820

Review 6.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

Review 7.  Long-term Opioids Linked to Hypogonadism and the Role of Testosterone Supplementation Therapy.

Authors:  Suganya Marudhai; Mauli Patel; Sharathshiva Valaiyaduppu Subas; Mohammad R Ghani; Vishal Busa; Ahmed Dardeir; Ivan Cancarevic
Journal:  Cureus       Date:  2020-10-05

8.  Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.

Authors:  Harry W Daniell
Journal:  J Pain       Date:  2007-11-01       Impact factor: 5.820

Review 9.  60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.

Authors:  David R Grattan
Journal:  J Endocrinol       Date:  2015-06-22       Impact factor: 4.286

Review 10.  Testosterone deficiency in non-cancer opioid-treated patients.

Authors:  F Coluzzi; D Billeci; M Maggi; G Corona
Journal:  J Endocrinol Invest       Date:  2018-10-20       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.